BSPBending Spoons S.p.A.

🇺🇸 US
43.75
USD
Analysis Scores
Lothien Robustness Score?
-
Neden bu skor?
Damodaran ?
-
Dalio Risk ?
-
Piotroski ?
N/A
Yetersiz çeyrek verisi: 4 mevcut, en az 5 gerekli
Graham ?
$2.9
Pahalı
Lothien Robustness Summary
51/100
Lothien Sağlamlık: Orta (51/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Olumlu | Pozitif: 8 | Negatif: 6 | Nötr: 1
Net Kâr Pozitif
Son çeyrekte $177M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Artışı
Net kâr bir önceki çeyreğe göre %+1454.4 arttı (-$13M → $177M). Kısa vadede olumlu momentum.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+171.1 arttı. Büyüme trendi sağlıklı.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+126.3 arttı. Şirket büyüyor.
Yüksek Net Kâr Marjı
Net kâr marjı %25.1. Her 100$ satıştan 25$ kâr kalıyor.
Yüksek Borçluluk
Net borç/özkaynak oranı 3.25x. Yüksek kaldıraç risk taşır, faiz yükü ağır olabilir.
Likidite Riski
Cari oran 0.64x — kısa vadeli borçları karşılama kapasitesi düşük. Nakit sıkışıklığı riski var.
Güçlü Nakit Üretimi
Serbest nakit akışı ($178M) kârın %100'sini nakit olarak üretiyor. Kâr kalitesi yüksek.
FAVÖK Büyümesi
FAVÖK çeyreklik %+98.7 arttı ($131M → $260M). Operasyonel verimlilik artıyor.
Yüksek F/K Uyarısı
Trailing F/K: 84.8. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Yüksek PD/DD
PD/DD: 22.08. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Yüksek EV/EBITDA
EV/EBITDA: 66.4. Pahalı değerleme.
Lothien Sağlamlık Skoru: 29/100
Bileşik algoritma değerlendirmesine göre şirketin finansal yapısı zayıf görünüyor.
Özkaynak Büyümesi
Özkaynak çeyreklik %+18.4 arttı. Şirket içsel birikimle güçleniyor.
Sonraki Çeyrek: Düşüş Beklentisi
Tahminine göre kâr %-43.5 düşebilir. Sonraki bilançoya dikkat.

Data date date not measured Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date date not measured
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Valuation
Potential?
-
Balance Sheet Analysis? Q2026/9
Fiyat TRAMA-99 hafif altında: %+0.0
Direnç seviyesi: TRAMA-99 = 43.75 USD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %25.1
Net profit margin %25.1 — very strong. Compared to previous quarter +27.1 point increase.
ROE - Return on Equity (TTM) %14.1
ROE %14.1 — moderate return on equity.
EBITDA Margin %36.9
EBITDA margin %36.9 — operationally very efficient.
Gross Profit Margin %65.8
Gross profit per revenue %65.8. Strong pricing power.
Free Cash Flow Margin (TTM) %17.5
TTM Free Cash Flow is %17.5'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio 84.8x Sector: 49.7x
F/K 84.8x — sector median's (49.7x) %71 above. Expensive zone.
P/B Ratio 22.08x Sector: 3.54x
PD/DD 22.08x — sector median's %524 above. Expensive book value.
EV/EBITDA 66.4x Sector: 25.2x
EV/EBITDA 66.4x — sector median's (25.2x) %163 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 0.64x
Current ratio 0.64x — short-term liabilities exceed current assets. Liquidity risk.
Net Debt / EBITDA 10.2x
Net Debt/EBITDA 10.2x — excessive leverage. Fragile debt profile.
Debt / Equity 3.88x
Debt/Equity 3.88x — very high leverage.
Interest Coverage 2.3x
Interest coverage 2.3x — limited buffer. May tighten if profitability drops.
Growth
Revenue Growth (YoY) %+126.3
Revenue YoY %126.3 grew (2026/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %+171.1
Net profit YoY %171.1 increased (2026/6) — extraordinary profit growth.
Score Explanations
Lothien Robustness
-
Weak robustness (29/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Potential
-
Minus %44.3 expected value (24.35) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %72.
Components: PE target: 25.75 | P/B target: 10.94 | EV/EBITDA target: 16.65 | DCF target: 10.94
Damodaran Valuation
-
Low Damodaran score (34/100). ROIC (%6.0) below cost of capital. DCF analysis does not support current price.
Weak
Dalio Risk Analysis
-
High debt risk (28/100). Interest coverage ratio 2.3x — acceptable. Debt/EBITDA 10.2x — high debt burden.
Leverage: 2/100 | Debt Service: 43/100 | Quality: 52/100
ROIC - Return on Capital
%6.0
ROIC (%6.0) cost of capital (9.3%) below → destroying value.
WACC: %9.3
DCF Discounted Cash Flow
7.34
DCF (7.34) current price %83.2 below — cash flows do not support current price.
Current price: 43.75
Debt Cycle Phase
Contraction
High debt service + falling revenues. Balance sheet under pressure.
Piotroski F-Score
—
Graham Intrinsic Value
$2.9
Expensive
⚖️ Sector Comparison
P/E Ratio
84.8x vs 49.7x
Sector median's %71 above — expensive
P/B Ratio
22.08x vs 3.54x
Compared to sector %524 more expensive (by book value)
EV/EBITDA
66.4x vs 25.2x
Compared to sector %163 higher EV/EBITDA
ROIC vs WACC
%6.0 vs %9.3 WACC
ROIC 3.3 bps below cost of capital
Net Profit Margin (TTM)
%6.1 vs %24.9 EBITDA margin
TTM net profit margin %6.1
↔
TRAMA-99 Trend — Near TRAMA
Price (43.75), TRAMA-99 line (43.75) at close levels (%+0.0). Important decision zone — breakout direction will determine the trend.
Price:: 43.75
TRAMA: 43.75
Difference: %+0.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

BSP — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.